| Completed | 4 | 255 | US, Europe, RoW | fluocinolone acetonide intraocular implant, NDC 24208-416-01, oral corticosteroid with immunosuppressive agents as needed, Permitted immunosuppressive agents:, - Alkylating agents, cyclophosphamide (Cytoxan), chlorambacil, - Antimetabolities, azathioprine (Imuran), azathioprine chlorambucil (Leukeran), methotrexate (Rheumatrex and others), mycophenolate mofetil (Cellcept), - T-cell inhibitors, cyclosporine (Neoral, Sandimmune and other trade names), tacrolimus, - Biologics, infliximab, daclizumab, other biologics | JHSPH Center for Clinical Trials, National Eye Institute (NEI) | Uveitis | 12/10 | 12/10 | | |
| Completed | 4 | 206 | US | Neo-Synalar Cream, NS 0.5%(0.35% neomycin base)/ FA 0.025% Cream, Sodium Lauryl Sulfate Aqueous Solution (0.40%), SLS, Saline | Noah Rosenberg, MD | Allergy | 06/14 | 06/14 | | |
EMMA, NCT04910503: Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema |
|
|
| Recruiting | 4 | 106 | Europe | Dexamethasone intravitreal implant, Fluocinolone Acetonide Intravitreal Implant | Centre Hospitalier Universitaire Dijon | Diabetic Macular Edema | 04/30 | 04/30 | | |
